Inventor · disambiguated record
Robert Pawliuk
Also filed as: PAWLIUK ROBERT
5 granted patents·8 pending applications·86 citations·filing 2001–2020
81Inventor score
Top patents by PatentIndex Score
13 records- 0195US7901671B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2005·Granted Mar 8, 2011·41 cites·17 claims
- 0293US9068199B2Therapeutic retroviral vectors for gene therapyLEBOULCH PHILIPPE·Filed 2011·Granted Jun 30, 2015·40 cites·18 claims
- 0390US10105451B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2015·Granted Oct 23, 2018·4 cites·11 claims
- 0481US10632212B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2018·Granted Apr 28, 2020·1 cites·17 claims
- 0571US11701435B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2020·Granted Jul 18, 2023·0 cites·20 claims
- 0660US2007072816A1Methods for inhibiting angiogenesisGENETIX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 0756US2011274669A1Therapeutic retroviral vectors for gene therapyLEBOULCH PHILIPPE·Filed 2010·Application pending·0 cites
- 0856US2004241141A1Method of treating arthritis using lentiviral vectors in gene therapyGENETIX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 0955US2004062751A1Methods for inhibiting angiogenesisGENETIX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1052US2007190030A1Method of treating arthritis using lentiviral vectors in gene therapyGENETIX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1147US2003139333A1Methods and compositions for promoting angiogenesisGENETIX PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1244US2002013261A1Methods and compositions for promoting angiogenesis using polyethylene glycol (PEG) polymersFiled 2001·Application pending·0 cites
- 1344US2002034501A1Methods and compositions for promoting angiogenesis using monocytesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Pawliuk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →